tegafur capsule 400 mg
balkan pharmaceuticals srl, sc - tegafurum - capsule - 400 mg
ftorafur 400 mg capsule
grindeks sa - tegafurum - capsule - 400 mg
ftorafur 400 mg capsule
grindeks sa - tegafurum - capsule - 400 mg
teysuno
nordic group b.v. - tegafur, gimeracil, oteracil - neoplasme de stomac - agenți antineoplazici - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.
brival 125 mg
berlin chemie ag menarini group - germania - brivudinum - compr. - 125mg - antivirale cu actiune directa nucleozide & nucleotide excl inhib. si reverstranscriptei
teysuno 15mg/4,35mg/11,8mg
nordic pharma - olanda - combinatii (tegafur+gimeracil+oteracil) - caps. - 15mg/4,35mg/11,8mg - antimetaboliti analogi ai bazelor pirimidinice
teysuno 20mg/5,8mg/15,8mg
nordic pharma - olanda - combinatii (tegafur+gimeracil+oteracil) - caps. - 20mg/5,8mg/15,8mg - antimetaboliti analogi ai bazelor pirimidinice
warfarin orion comprimate 3 mg
orion corporation - warfarinum - comprimate - 3 mg
warfarin orion comprimate 5 mg
orion corporation - warfarinum - comprimate - 5 mg
warfarin orion 3 mg comprimate
orion corporation - warfarinum - comprimate - 3 mg